Warner Bryce M
Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
Pathogens. 2021 Mar 1;10(3):275. doi: 10.3390/pathogens10030275.
Viral hemorrhagic fever viruses come from a wide range of virus families and are a significant cause of morbidity and mortality worldwide each year. Animal models of infection with a number of these viruses have contributed to our knowledge of their pathogenesis and have been crucial for the development of therapeutics and vaccines that have been approved for human use. Most of these models use artificially high doses of virus, ensuring lethality in pre-clinical drug development studies. However, this can have a significant effect on the immune response generated. Here I discuss how the dose of antigen or pathogen is a critical determinant of immune responses and suggest that the current study of viruses in animal models should take this into account when developing and studying animal models of disease. This can have implications for determination of immune correlates of protection against disease as well as informing relevant vaccination and therapeutic strategies.
病毒性出血热病毒来自多种病毒科,是每年全球发病和死亡的重要原因。感染多种此类病毒的动物模型有助于我们了解其发病机制,对于已获批供人类使用的治疗方法和疫苗的开发至关重要。这些模型大多使用人工高剂量病毒,以确保在临床前药物开发研究中出现致死情况。然而,这可能会对产生的免疫反应产生重大影响。在此,我将讨论抗原或病原体的剂量如何成为免疫反应的关键决定因素,并建议在开发和研究疾病动物模型时,当前对动物模型中病毒的研究应考虑到这一点。这可能会对确定疾病防护的免疫相关因素以及为相关疫苗接种和治疗策略提供信息产生影响。